The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation
Abstract
Aims The aim of this study is to assess the efficacy and safety of lubiprostone in adults with chronic constipation. Methods This multicenter, parallel-group trial enrolled 237 patients with chronic constipation and randomized them to 4 weeks of double-blind treatment with oral lubiprostone 24 mcg or placebo twice daily. The primary efficacy endpoint was the number of spontaneous bowel movements (SBMs) after 1 week of treatment. Secondary evaluations included SBMs at weeks 2, 3, and 4; percentage of patients with a SBM within 24 h of first study dose; stool consistency; degree of straining; constipation severity; abdominal bloating and discomfort; global treatment effectiveness; and safety assessments. Results Lubiprostone-treated patients experienced greater mean numbers of SBMs at week 1 compared with placebo (5.89 versus 3.99, P = 0.0001), with significantly greater percentages having SBMs within 24 h of the first dose (61.3% versus 31.4%, P or =4 SBM per week) were significantly greater among lubiprostone-treated patients compared with placebo (P Conclusions In patients with chronic constipation, lubiprostone produced a bowel movement in the majority of individuals within 24 h of initial dosing, with sustained improvement in frequency as well as other constipation symptoms over 4 weeks of treatment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The pooled data showed that lubiprostone resulted in an increased number of SBMs per week compared with placebo (MD 1.98, 95% CI 1.17-2.79).”
Citations
Cites
Epidemiology of Constipation in North America: A Systematic Review
Higgins, P. D., & Johanson, J. F. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04114.x · Cited by 1,080
Self-citationChronic constipation: a survey of the patient perspective
JOHANSON, J. F., & KRALSTEIN, J. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03238.x · Cited by 617 · cited 1×
“Additionally, those with constipation experience significant decrements in quality of life and functional status, including reduced productivity and increased numbers of missed days of work, school or other activities [6].”
BackgroundSelf-citationStewart, W. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00701-7 · Cited by 492
Systematic Review on the Management of Chronic Constipation in North America
Brandt, L. J., Prather, C. M., Quigley, E. M. M., Schiller, L. R., Schoenfeld, P., & Talley, N. J. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.50613_2.x · Cited by 342
Johanson, J. F., Morton, D., Geenen, J., & Ueno, R. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01524.x · Cited by 331
Self-citationCamilleri, M., Bharucha, A. E., Ueno, R., Burton, D., Thomforde, G. M., Baxter, K., McKinzie, S., & Zinsmeister, A. R. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00264.2005 · Cited by 253
Self-citationSPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents
Cuppoletti, J., Malinowska, D. H., Tewari, K. P., Li, Q.-J., Sherry, A. M., Patchen, M. L., & Ueno, R. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00528.2003 · Cited by 232
Self-citationJOHANSON, J. F., & UENO, R. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03320.x · Cited by 230
Self-citationA Gap in Our Understanding: Chronic Constipation and Its Comorbid Conditions
Talley, N. J., Lasch, K. L., & Baum, C. L. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.07.005 · Cited by 64
Geographic Distribution of Constipation in the United States
Johanson, J. F. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.00188.x · Cited by 39
Self-citation
Research works printed but not linked: 1
- Ueno R, Osama H, Habe T, et al. Oral spi-0211 increases intestinal fluid secretion and chloride concentration without altering serum electrolyte levels (abstract). Gastroenterology. 2004;126:298.
Cited by
Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.031 · Cited by 2,866
Ford, A. C., Moayyedi, P., Lacy, B. E., Lembo, A. J., Saito, Y. A., Schiller, L. R., Soffer, E. E., Spiegel, B. M. R., & Quigley, E. M. M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.187 · Cited by 645
Management of functional constipation in children and adults
Vriesman, M. H., Koppen, I. J. N., Camilleri, M., Di Lorenzo, C., & Benninga, M. A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0222-y · Cited by 457
Ford, A. C., & Suares, N. C. (2011) · Gut · doi:10.1136/gut.2010.227132 · Cited by 378
Chronic Constipation in the Elderly
Gallegos-Orozco, J. F., Foxx-Orenstein, A. E., Sterler, S. M., & Stoa, J. M. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.349 · Cited by 297
“In this setting, 24 μg twice daily has been shown to be effective in both open-label and randomized controlled trials (”
Background
Metadata
- Authors
- Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R.
- Affiliations
- Wake Research (US)
- University of North Carolina at Chapel Hill (US)
- University of Illinois Chicago, Rockford campus (US)
- Corresponding author
- Barish, Charles F.
- ORCID
- Drossman, Douglas
- Venue
- Digestive Diseases and Sciences
- Published
- 2009-12-11
- Volume
- 55
- Issue
- 4
- Pages
- 1090-1097
- ISSN
- 0163-2116 (ISSN-L)
- 1573-2568
- OpenAlex
- W2003147380
- Cited by
- 192
- References
- 13
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 10 · 2023: 11 · 2022: 5 · 2021: 10 · 2020: 18 · 2019: 7 · 2018: 10 · 2017: 8 · 2016: 12 · 2015: 18 · 2014: 18 · 2013: 13 · 2012: 13
- FWCI
- 13.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Digestive Diseases and Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Urology › Pelvic floor disorders treatments
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Keywords
- lubiprostone, chronic constipation, prokinetic agents, spontaneous bowel movements, stool consistency, straining, bloating, gastrointestinal adverse effects, drug safety and efficacy
- MeSH terms
- Lubiprostone, Adult, Alprostadil, Chronic Disease, Constipation, Defecation, Double-Blind Method, Female, Follow-Up Studies, Humans, Male, Middle Aged, Treatment Outcome, Laxatives
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation. https://app.cochat.ai/papers/10.1007/s10620-009-1068-x
- The paper
- Barish, C. F., Drossman, D., Johanson, J. F., & Ueno, R. (2010). Efficacy and Safety of Lubiprostone in Patients with Chronic Constipation. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-009-1068-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.